Cargando…

Corrigendum: RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	XIA & HE Publishing Inc. 2023
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412714/ https://www.ncbi.nlm.nih.gov/pubmed/37577227 http://dx.doi.org/10.14218/JCTH.2023.00010

Ejemplares similares

RP11-40C6.2 Inactivates Hippo Signaling by Attenuating YAP1 Ubiquitylation in Hepatitis B Virus-associated Hepatocellular Carcinoma
por: Zhuo, Han, et al.
Publicado: (2023)

Downregulation of CENPK Suppresses Hepatocellular Carcinoma Malignant Progression through Regulating YAP1 [Corrigendum]
Publicado: (2022)

Corrigendum to “Antiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway”
por: Zhang, Jian, et al.
Publicado: (2020)

Corrigendum to “TNF-α is a potential therapeutic target to overcome sorafenib resistance in hepatocellular carcinoma” [EBioMedicine 40 (2019) 446–456]
por: Tan, Wenliang, et al.
Publicado: (2022)

Correction to ‘Regulation of androgen receptor and histone deacetylase 1 by Mdm2-mediated ubiquitylation’
por: Gaughan, Luke, et al.
Publicado: (2021)

Corrigendum to “Hydrogen-Rich Saline Attenuates Cardiac and Hepatic Injury in Doxorubicin Rat Model by Inhibiting Inflammation and Apoptosis”
por: Gao, Yunan, et al.
Publicado: (2017)

The de-ubiquitylating enzymes USP26 and USP37 regulate homologous recombination by counteracting RAP80
por: Typas, Dimitris, et al.
Publicado: (2016)

YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019)

Corrigendum to “TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice” [EBioMedicine (2018) 54–62]
por: Wang, Zhen, et al.
Publicado: (2018)

Corrigendum to Solanine Attenuated Hepatocarcinoma Migration and Invasion Induced by Acetylcholine
Publicado: (2022)

Ferulic acid attenuates liver fibrosis and hepatic stellate cell activation via inhibition of TGF-β/Smad signaling pathway [Corrigendum]
por: Mu, Mao, et al.
Publicado: (2019)

CORRIGENDUM: Correction of funding statement in ACKNOWLEDGEMENTS section: Epigenetic inactivation of RUNX3 in colorectal cancer
por: Shin, Eung Jin, et al.
Publicado: (2018)

Corrigendum to ‘PRAS40 hyperexpression promotes hepatocarcinogenesis’ [EBioMedicine 51 (2020) 102,604]
por: Qi, Zhaolai, et al.
Publicado: (2020)

Corrigendum to “Melatonin Reverses the Loss of Stemness Induced by TNF-α in Human Bone Marrow Mesenchymal Stem Cells through Upregulation of YAP Expression”
por: Wang, Xudong, et al.
Publicado: (2022)

Daclatasvir: potential role in hepatitis C [Corrigendum]
Publicado: (2014)

Corrigendum to “Spontaneous Resolution of Symptomatic Hepatic Sarcoidosis”
por: Nguyen, Viva, et al.
Publicado: (2018)

Corrigendum to “Prebiotics: A Novel Approach to Treat Hepatocellular Carcinoma”
por: Fatima, Naz, et al.
Publicado: (2017)

Overexpression of APC11 predicts worse survival in lung adenocarcinoma [Corrigendum]
Publicado: (2019)

Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma
por: Hu, Hao, et al.
Publicado: (2020)

Corrigendum to’ Morphine dependence is attenuated by red ginseng extract and ginsenosides Rh2, Rg3, and compound K’ [Journal of Ginseng Research Volume 40, Issue 4, October 2016, Pages 445-452]
por: Yayeh, Taddesse, et al.
Publicado: (2023)

Corrigendum to “Cholesterol confers ferroptosis resistance onto myeloid-biased hematopoietic stem cells and prevents irradiation-induced myelosuppression” [Redox Biol. 62 (2023) 102661]
por: Liu, Chaonan, et al.
Publicado: (2023)

Corrigendum to “Partial compartmentalisation of HIV-1 subtype C between lymph nodes, peripheral blood mononuclear cells and plasma” [Virology 582 (2023) 62–70]
por: Jeewanraj, Neschika, et al.
Publicado: (2023)

Drug-Related Hypertension Associated with the Efficacy of Apatinib on Hepatocellular Carcinoma [Corrigendum]
Publicado: (2020)

Corrigendum to “The Oncogenic Role of ARG1 in Progression and Metastasis of Hepatocellular Carcinoma”
por: You, Jia, et al.
Publicado: (2019)

Corrigendum to: Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
por: Park, Mijin, et al.
Publicado: (2022)

Dedifferentiation by adenovirus E1A due to inactivation of Hippo pathway effectors YAP and TAZ
por: Zemke, Nathan R., et al.
Publicado: (2019)

S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis [Corrigendum]
Publicado: (2013)

Corrigendum to “Sodium Tanshinone IIA Sulfonate Attenuates Erectile Dysfunction in Rats with Hyperlipidemia”
por: Zhong, Liren, et al.
Publicado: (2020)

Corrigendum to “Comparison of Different Histone Deacetylase Inhibitors in Attenuating Inflammatory Pain in Rats”
por: Zhou, Jing, et al.
Publicado: (2021)

Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)

YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma
por: LaQuaglia, Michael J., et al.
Publicado: (2016)

Corrigendum to “Transmission Model of Hepatitis B Virus with the Migration Effect”
por: Khan, Muhammad Altaf, et al.
Publicado: (2016)

Corrigendum to “Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents” [J Hosp Infect 104 (2020) 246–251]
por: Kampf, G., et al.
Publicado: (2020)

Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms
por: Dobrokhotov, Oleg, et al.
Publicado: (2018)

Corrigendum to “Cell Cycle Genes Are Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma”
por: Liping, Xu, et al.
Publicado: (2020)

Clinical Significance of the HHLA2 Protein in Hepatocellular Carcinoma and the Tumor Microenvironment [Corrigendum]
Publicado: (2021)

Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma [Corrigendum]
Publicado: (2023)

Corrigendum to “Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARSCoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study” [Life Sci. 253 (2020) 117592]
por: Elfiky, Abdo A.
Publicado: (2020)

MicroRNA-93 promotes angiogenesis and attenuates remodeling via inactivation of the Hippo/Yap pathway by targeting Lats2 after myocardial infarction
por: Ma, Chengjie, et al.
Publicado: (2020)

Corrigendum: Magnetic Resonance Elastography and Diffusion Weighted Imaging in the Evaluation of Hepatic Fibrosis in Chronic Hepatitis B
por: Hennedige, Tiffany P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_v9o201cjmmi84dcmhbl5n2vl3f